| Literature DB >> 30100983 |
Abstract
Entities:
Keywords: aging; growth; lifespan; mTOR; rapalogs
Year: 2018 PMID: 30100983 PMCID: PMC6084391 DOI: 10.18632/oncotarget.25788
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1Rapamycin slows aging
A. Cell culture. In proliferating cells, rapamycin (RAPA) slows growth. When the cell is arrested, then rapamycin slows down geroconversion to senescence. Geroconversion is a continuation of growth in non-dividing (arrested) cells. B. The organism. When development is completed, then mTOR drives aging and age-related diseases. Thus, aging and its diseases are quasi-programmed (a continuation of developmental growth). RAPA slows aging and delays diseases.
Figure 2Rapamycin decreases hyper-functions, a key feature of aging, thus preventing functional decline